Frontlight ResearchEarly access
Hodgkin lymphoma trials in Italy
25 of 29 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Rome, Turin
- Age
- Up to 17 years
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 - Phase 2Taking peopleEvaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Where
- Brescia, Meldola, Milan, Naples, Rozzano
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00 - Phase 1/2Taking peopleA Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Where
- Rome
- Age
- 6 months to 17 years
- People
- 370 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00 - Phase 1/2Taking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Candiolo, Milan, Naples, Reggio Emilia, Rome, Rozzano
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - Phase 1/2Active, not recruitingAn early study to investigate a new medicine for Subjects with Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
- Where
- Bergamo, Bologna, Naples
- Age
- 18 years and over
- People
- 204 worldwide
- Run by
- Celgene Corp.
See details and how to joinNCT03930953 · EU 2024-515690-10-00 - Phase 1Not yet taking people in ItalyA Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- Bologna, Milan
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00 - Phase 1Not yet taking people in ItalyA Study of ARC-02 in B-cell NHL
- Where
- Aviano, Bergamo, Bologna, Rozzano
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - Phase 1/2CompletedA Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]
- Where
- Milan
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- Cellectis
See details and how to joinNCT05607420 · EU 2022-501607-27-00 - Phase 1Taking peopleAn early Phase 1b Study to assess how safe and effective is the treatment with drugs, called Mosunetuzumab or Glofitamab in Combination with drugs called, CC-220 and CC-99282 in Patients with B-Cell Non-Hodgkin Lymphoma.
- Where
- Bologna, Brescia, Meldola, Milan, Pisa
- Age
- 18 years and over
- People
- 52 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-505185-28-00 - Phase 1Not yet taking people in ItalyA First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma
- Where
- Bergamo, Bologna, Candiolo, Turin
- Age
- 18 years and over
- People
- 34 worldwide
- Run by
- Kyowa Kirin Inc.
See details and how to joinNCT07192471 · EU 2025-522523-96-00 - Phase 2Taking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Alexandria, Bologna, Busto Arsizio, Milan
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - Phase 1/2Taking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Alessandria, Bologna, Milan
- Age
- 12 years and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - Phase 3Not yet taking people in ItalyA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Meldola, Ravenna, Rome, Tricase
- Age
- 18 years and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - Phase 2Taking peoplePhase II study: efficacy and safety of tislelizumab in patients with de novo Hodgkin lymphoma unsuitable for standard chemotherapy
- Where
- Alexandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo, Reggio Emilia, Rome, Rozzano
- Age
- 65 years and over
- People
- 25
- Run by
- Fondazione Italiana Linfomi Onlus
See details and how to join2022-503090-11-00 - Phase 3Taking peopleRandomized study to protect from radiation iatrogenic hypothyroidism patients with medulloblastoma (any stage, any biological risk) and pediatric patients with Hodgkin lymphoma and non-Hodgkin lymphoma needing radiation therapy on thyroid site - WINHYPO 2021
- Where
- Milan
- People
- 65
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2024-512642-42-00 - Phase 1/2Taking peopleA study to evaluate safety and clinical activity of GSK5926371 in adult participants with relapsed or refractory B-NHL
- Where
- Alexandria, Milan, Rozzano
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Glaxosmithkline Research & Development Limited
See details and how to join2025-524915-36-00 - Phase 1Taking peopleA Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
- Where
- Bergamo, Bologna, Brescia, Milan
- Age
- 18 years and over
- People
- 121 worldwide
- Run by
- ADC Therapeutics SA
See details and how to joinNCT04970901 · EU 2024-512089-32-00 - Phase 3Taking peoplePET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma
- Where
- Alessandria, Avellino, Aviano, Bergamo, Brescia, Cagliari, Candiolo, Catania, Cuneo, Florence, Genova, Latina, Milan, Novara, Padova, Palermo, Pavia, Perugia, Piacenza, Ravenna, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo, Siena, Terni, Torino, Treviso, Trieste, Udine, Verona
- Age
- 18 years and over
- People
- 518
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT07256158 - Phase 2Taking peopleEfficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy
- Where
- Alessandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo, Reggio Emilia, Roma, Rozzano
- Age
- 65 years and over
- People
- 28
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT05977673 - Phase 1/2Taking peopleA trial to learn how safe AZD4512 is with and without other cancer drugs and how it works in the bodies of people with B-cell non-Hodgkin lymphoma (B-NHL)
- Where
- Bologna, Milan
- Age
- 18 years and over
- People
- 18
- Run by
- AstraZeneca AB
See details and how to join2025-522371-29-00 - Phase 3CompletedA trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
- Where
- Aviano, Brescia, Meldola, Novara, Roma, Siena, Varese
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00 - Phase 2Taking peopleClinical trial with a combination of Rituximab and Golcadomide as first line therapy for older frail patients with Diffuse Large B-cells non-Hodgkin Lymphoma
- Where
- Alexandria, Ancona, Avellino, Aviano, Brescia, Florence, Milan, Monza, Padova, Palermo, Pescara, Piacenza, Ravenna, Reggio Emilia, Rome, Siena, Trieste, Turin, Verona
- Age
- 65 years and over
- People
- 47
- Run by
- Fondazione Italiana Linfomi Ets
See details and how to join2023-506206-38-00 - Phase 1Taking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Alexandria, Milan, Turin, Verona
- Age
- 18 years and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - Phase 2Taking peopleRadiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTING
- Where
- Ancona, Bari, Bergamo, Brescia, Cagliari, Catania, Cuneo, Genoa, Milan, Naples, Padova, Palermo, Pavia, Rome, Venice
- Age
- 18 years and over
- People
- 145 worldwide
- Run by
- Medical University Of Gdansk
See details and how to join2024-515063-66-00 - Phase 1/2Taking peopleAllogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
- Where
- Bergamo, Monza
- Age
- 1 year and over
- People
- 29
- Run by
- Fondazione Matilde Tettamanti Menotti De Marchi Onlus
See details and how to joinNCT05869279 · EU 2023-505511-20-00